FDA Drug Application (018965) for NAPROSYN by ATNAHS PHARMA US

Back to FDA Applications sponsored by ATNAHS PHARMA US

Application Number018965
Product Number001
FormSUSPENSION;ORAL
Dosage25MG/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNAPROSYN
Active IngredientNAPROXEN

Active IngredientCount
List of drugs with Active Ingredient NAPROXEN8


Back to FDA Applications sponsored by ATNAHS PHARMA US